Classificatie
- Anatomische hoofdgroepJAnti-infectiva voor systemisch gebruik
- Therapeutische subgroepJ05
- Farmacologische subgroepJ05A
- Chemische subgroepJ05AF
- Chemische stofJ05AF04Stavudine
Waar het geregistreerd is
Elk register met het aantal geneesmiddelen en een paar ervan.
Verenigde Staten
FDA · 14 geneesmiddelen
- Stavudine1MG/ML · for solution · Cipla LTD
- Zerit1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · for solution · Bristol
- Zerit15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · capsule · Bristol
- Zerit XR100MG, 37.5MG, 50MG … · capsule, extended release · Bristol Myers Squibb
Canada



